Javier Martínez‐Useros

Author

Hospital Universitario Fundación Jiménez Díaz ORCID

Also Known As

J Martínez-Useros, J. Martinez Useros, J. Martinez-Useros, J. Martínez-Useros, Javier Martinez Useros, Javier Martinez-Useros, Javier Martinez‐Useros, Javier Martínez Useros, Javier Martínez-Useros, Javier Martínez-Useros (9046202)

106

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Fundación Jiménez Díaz Universidad Autónoma de Madrid Hospital Clínico San Carlos Instituto de Salud Carlos III Unidad Funcional de Investigación de Enfermedades Crónicas

About

Javier Martínez‐Useros is an author at Hospital Universitario Fundación Jiménez Díaz specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	465
2	Engineering	2	2	51
3	Health Sciences	1	1	11
4	Social Sciences	1	1	36
5	Allergy	1	1	31

Javier Martínez‐Useros

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis Laurence Wurth, Panagiotis Papasaikas, David Olmeda, Cancer Cell	2016	158
PP2A Inhibition Is a Common Event in Colorectal Cancer and Its Restoration Using FTY720 Shows Promising Therapeutic Potential Ion Cristóbal, Rebeca Manso, Raúl Rincón, Molecular Cancer Therapeutics Tumor BiologyOncologyChemoprevention StrategyCommon EventPp2a Activity	2014	124
Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer Óscar Aguilera, María Muñoz-Sagastibelza, Blanca Torrejón, Oncotarget	2016	81
KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study Nuria Garcia-Carbonero, Javier Martínez‐Useros, Weiyao Li, Cells	2020	74
A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma Elena Beltrán, Vicente Fresquet, Javier Martínez‐Useros, Proceedings of the National Academy of Sciences	2011	56
High‐throughput sequencing analysis of the chromosome 7q32 deletion reveals <scp>IRF</scp>5 as a potential tumour suppressor in splenic marginal‐zone lymphoma Vicente Fresquet, Eloy F. Robles, Anton Parker, British Journal of Haematology	2012	48
Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer Óscar Aguilera, José Manuel González‐Sancho, Sandra Zazo, Oncotarget Tumor BiologyTranscriptional RegulationNuclear Dkk-1 ExpressionMedicinePoor Clinical Outcome	2015	43
Identification of prefrontal cortex protein alterations in Alzheimer’s disease María Garranzo‐Asensio, Pablo San Segundo‐Acosta, Javier Martínez‐Useros, Oncotarget Vascular Dementia PatientsHealthy SubjectsNeurochemical BiomarkersAlzheimer ’Social Sciences	2018	36
Identification of tumor-associated antigens with diagnostic ability of colorectal cancer by in-depth immunomic and seroproteomic analysis María Garranzo‐Asensio, Pablo San Segundo‐Acosta, Carmen Povés, Journal of Proteomics MedicineImmunologyTumor-associated AntigensColorectal CancerPathology	2020	36
Multiplexed Biosensing Diagnostic Platforms Detecting Autoantibodies to Tumor-Associated Antigens from Exosomes Released by CRC Cells and Tissue Samples Showed High Diagnostic Ability for Colorectal Cancer Ana Montero‐Calle, Itziar Aranguren-Abeigon, María Garranzo‐Asensio, Engineering EngineeringImmunologyTumor-associated AntigensPathologyCrc Patients	2021	35

Page 1